ZG02 Improved Hepatic Glucose Metabolism and Insulin Sensitivity via Activation of AMPK/Sirt1 Signaling Pathways in a High-fat Diet/Streptozotocin-induced Type 2 Diabetes Model

References

• Jaeger A, Zollinger L, Saely CH, et al. Circulating microRNAs −192 and −194 are associated with the presence and incidence of diabetes mellitus. Sci Rep. 2018;8(1):14274. doi:10.1038/s41598-018-32274-9.
   PubMedGoogle Scholar
• Neuen BL, Young T, Heerspink HJL, et al. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. The Lancet Diabetes & Endocrinology. 2019;7(11):845–854. doi:10.1016/S2213-8587(19)30256-6.
   PubMed Web of Science ®Google Scholar
• Parkman HP, Wilson LA, Farrugia G, et al. Delayed Gastric Emptying Associates With Diabetic Complications in Diabetic Patients With Symptoms of Gastroparesis. Am J Gastroenterol. 2019;114(11):1778–1794. doi:10.14309/ajg.0000000000000410.
   PubMed Web of Science ®Google Scholar
• Bader E, Migliorini A, Gegg M, et al. Identification of Proliferative and Mature β-cells in the Islets of Langerhans. Nature. 2016;535(7612):430–434. doi:10.1038/nature18624.
   PubMedGoogle Scholar
• Amiel SA, Aschner P, Childs B, et al. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endo. 2019;7(5):385–396. doi:10.1016/S2213-8587(18)30315-2.
   PubMed Web of Science ®Google Scholar
• Fletcher B, Gulanick M, Lamendola C, et al. Risk Factors for Type 2 Diabetes Mellitus. J Cardiovasc Nurs. 2002;16(2):17–23. doi:10.1097/00005082-200201000-00003.
   PubMedGoogle Scholar
• International Diabetes Federation. IDF Diabetes Atlas. 9. Brussels, Belgium: International Diabetes Federation; 2019. doi:10.1016/j.diabres.2019.107843.
   Google Scholar
• Khunti K, Chatterjee S, Gerstein HC, et al. Do Sulphonylureas Still Have a Place in Clinical Practice? Lancet Diabetes Endo. 2018;6(10):821–832. doi:10.1016/S2213-8587(18)30025-1.
   PubMed Web of Science ®Google Scholar
• Kennedy KE, Teng C, Patek TM, et al. Hypoglycemia Associated With Antibiotics Alone and in Combination With Sulfonylureas and Meglitinides: an Epidemiologic Surveillance Study of the FDA Adverse Event Reporting System (FAERS). Drug Saf. 2020;43(4):363–369. doi:10.1007/s40264-019-00901-7.
   PubMedGoogle Scholar
• Kwon MJ, Lee YJ, Jung HS, et al. The direct effect of lobeglitazone, a new thiazolidinedione, on pancreatic beta cells: A comparison with other thiazolidinediones. Diabetes Res Clin Pract. 2019;151:209–223. doi:10.1016/j.diabres.2019.04.006.
   PubMed Web of Science ®Google Scholar
• Moelands SV, Lucassen PL, Akkermans RP, et al. Alpha-glucosidase Inhibitors for Prevention or Delay of Type 2 Diabetes Mellitus and Its Associated Complications in People at Increased Risk of Developing Type 2 Diabetes Mellitus. Cochrane Database Syst Rev. 2018;12(12):CD005061. doi:10.1002/14651858.CD005061.pub3.
   PubMedGoogle Scholar
• Dhameja M, Gupta P. Synthetic Heterocyclic Candidates as Promising α-glucosidase Inhibitors: an Overview. Eur J Med Chem. 2019;176:343–377. doi:10.1016/j.ejmech.2019.04.025.
   PubMed Web of Science ®Google Scholar
• Gentilella R, Pechtner V, Corcos A, et al. Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same? Diabetes Metab Res Rev. 2019;35(1):3070. doi:10.1002/dmrr.3070.
   PubMed Web of Science ®Google Scholar
• Choi B, Lee S, Kim S-M, et al. Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells. Circulation. 2017;135(20):1935–1950. doi:10.1161/CIRCULATIONAHA.116.024270.
   PubMed Web of Science ®Google Scholar
• Katsiki N, Perakakis N, Mantzoros C. Effects of Sodium-Glucose co-transporter-2 (SGLT2) Inhibitors on Non-Alcoholic Fatty Liver disease/non-alcoholic Steatohepatitis: ex Quo Et Quo Vadimus? Metabolism. 2019;98:iii–ix. doi:10.1016/j.metabol.2019.07.009
   PubMedGoogle Scholar
• Trefts E, Gannon M, Wasserman DH. The Liver. Curr Biol. 2017;27(21):1147–1151. doi:10.1016/j.cub.2017.09.019.
   PubMed Web of Science ®Google Scholar
• Yan H, Yang W, Zhou F, et al. Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1. Diabetes. 2019;68(2):291–304. doi:10.2337/db18-0638.
   PubMed Web of Science ®Google Scholar
• Puigserver P, Rhee J, Donovan J, et al. Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction. Nature. 2003;423(6939):550–555. doi:10.1038/nature01667.
   PubMed Web of Science ®Google Scholar
• Eugenin EA, Valdebenito S, Gorska AM, et al. Gap Junctions Coordinate the Propagation of Glycogenolysis Induced by Norepinephrine in the Pineal Gland. J Neurochem. 2019;151(5):558–569. doi:10.1111/jnc.14846.
   PubMedGoogle Scholar
• Barr D, Szennyes E, Bokor É, et al. Identification of C -β-d-Glucopyranosyl Azole-Type Inhibitors of Glycogen Phosphorylase That Reduce Glycogenolysis in Hepatocytes: In Silico Design, Synthesis, in Vitro Kinetics, and ex Vivo Studies. ACS Chem Biol. 2019;14(7):1460–1470. doi:10.1021/acschembio.9b00172.
   PubMedGoogle Scholar
• Hirase H, Akther S, Wang X, et al. Glycogen Distribution in Mouse Hippocampus. J Neurosci Res. 2019;97(8):923–932. doi:10.1002/jnr.24386.
   PubMedGoogle Scholar
• Saslow LR, Mason AE, Kim S, et al. An Online Intervention Comparing a Very Low-Carbohydrate Ketogenic Diet and Lifestyle Recommendations Versus a Plate Method Diet in Overweight Individuals With Type 2 Diabetes: A Randomized Controlled Trial. J Med Internet Res. 2017;19(2):36. doi:10.2196/jmir.5806
   PubMedGoogle Scholar
• Chakravarthy M, Parsons S, Lassman ME, et al. Effects of 13-Hour Hyperglucagonemia on Energy Expenditure and Hepatic Glucose Production in Humans. Diabetes. 2017;66(1):36–44. doi:10.2337/db16-0746.
   PubMed Web of Science ®Google Scholar
• Cuthbertson DJ, Shojaee-Moradie F, Sprung VS, et al. Dissociation Between Exercise-Induced Reduction in Liver Fat and Changes in Hepatic and Peripheral Glucose Homoeostasis in Obese Patients With Non-Alcoholic Fatty Liver Disease. Clin Sci. 2016;130(2):93–104. doi:10.1042/CS20150447.
   Web of Science ®Google Scholar
• Zhang J-Q, Li S-M, Ma X, et al. Discovery of Tetrahydrocarbazoles With Potent Hypoglycemic and Hypolipemic Activities. Eur J Med Chem. 2018;150:102–112. doi:10.1016/j.ejmech.2018.02.069.
   PubMed Web of Science ®Google Scholar
• Xuguang H, Aofei T, Tao L, et al. Hesperidin ameliorates insulin resistance by regulating the IRS1-GLUT2 pathway via TLR4 in HepG2 cells. Phytother Res. 2019;33(6):1697–1705. doi:10.1002/ptr.6358.
   PubMedGoogle Scholar
• Chen L, Teng H, Cao H, et al. Chlorogenic acid and caffeic acid from Sonchus oleraceus Linn synergistically attenuate insulin resistance and modulate glucose uptake in HepG2 cells. Food Chem Toxicol. 2019;127:182–187. doi:10.1016/j.fct.2019.03.038.
   PubMed Web of Science ®Google Scholar
• Yu Z, Shiguo C, Yang WC, et al. Proanthocyanidins from Chinese bayberry leaves regulate lipid metabolism and glucose consumption by activating AMPK pathway in HepG2 cells.. J Funct Foods. 2014;29:217–225. doi:10.1016/j.jff.2016.12.030.
   Google Scholar
• Kuo C-S, Chen J-S, Lin L-Y, et al. Inhibition of Serine Protease Activity Protects Against High Fat Diet-Induced Inflammation and Insulin Resistance. Sci Rep. 2020;10(1):1725. doi:10.1038/s41598-020-58361-4
   PubMed Web of Science ®Google Scholar
• Mesallamy HO, Hamdy NM, Mostafa DM, et al. The serine protease granzyme B as an inflammatory marker, in relation to the insulin receptor cleavage in human obesity and type 2 diabetes mellitus. J Interferon Cytokine Res. 2014;34(3):179–186. doi:10.1089/jir.2013.0059
   PubMedGoogle Scholar
• Chakraborty S, Datta S, Ghosh S. Induction of autophagy under nitrosative stress: A complex regulatory interplay between SIRT1 and AMPK in MCF7 cells. Cell Signal. 2018;8:109411. doi:10.1016/j.cellsig.2019.109411
   Google Scholar
• Shaw RJ, et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science. 2005;310(5754):1642–1646. doi:10.1126/science.1120781
   PubMed Web of Science ®Google Scholar
• Carling D. AMPK signalling in health and disease.[J]. Curr Opin Cell Biol. 2017;45:31–37. doi:10.1016/j.ceb.2017.01.005.
   PubMed Web of Science ®Google Scholar
• Boyer PD, Chance B, Ernster L, et al. Oxidative phosphorylation and photophosphorylation. Annual Review of Biochemistry. 2019;97(1):955–1026. doi:10.1002/jnr.24386
   Google Scholar
• Zang M, Zuccollo A, Hou X, et al. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J Biol Chem. 2004;279:47898–47905. doi:10.1074/jbc.M408149200.
   PubMed Web of Science ®Google Scholar
• Carling D, Thornton C, Woods A, et al. AMP-activated protein kinase: new regulation, new roles? Biochem J. 2012;445:11–27. doi:10.1042/BJ20120546.
   PubMed Web of Science ®Google Scholar
• Cokorinos EC, Delmore J, Reyes AR, et al. Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice. Cell Metab. 2017;25:1147–1159. doi:10.1016/j.cmet.2017.04.010
   PubMed Web of Science ®Google Scholar
• Fullerton MD, Galic S, Marcinko K, et al. Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. Nat Med. 2013;19:1649–1654. doi:10.1038/nm.3372.
   PubMed Web of Science ®Google Scholar
• Settembre C, Zoncu R, Medina DL, et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 2012;31:1095–1108. doi:10.1038/emboj.2012.32.
   PubMed Web of Science ®Google Scholar
• Myers RW, Guan HP, Ehrhart J, et al. Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy. Science. 2017;357:507–511. doi:10.1126/science.aah5582.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Datta S, Ghosh S, et al. Induction of autophagy under nitrosative stress: A complex regulatory interplay between SIRT1 and AMPK in MCF7 cells. Cell Signal. 2019;64:109411. doi:10.1016/j.cellsig.2019.109411.
   PubMedGoogle Scholar
• Dugan LL, You YH, Ali SS, et al. AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function. J Clin Invest. 2013;123(11):4888–4899. doi:10.1172/JCI66218.
   PubMed Web of Science ®Google Scholar
• Kim YD, Park KG, Lee YS, et al. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes. 2008;57(2):306–314. doi:10.2337/db07-0381.
   PubMed Web of Science ®Google Scholar
• Lei Y, Wang J, Wang D, et al. SIRT1 in forebrain excitatory neurons produces sexually dimorphic effects on depression-related behaviors and modulates neuronal excitability and synaptic transmission in the medial prefrontal cortex. Mol Psychiatry. 2020;25(5):1094–1111. doi:10.1038/s41380-019-0352-1.
   PubMedGoogle Scholar
• Canto C, Auwerx J. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol. 2009;20:98–105. doi:10.1097/MOL.0b013e328328d0a4.
   PubMed Web of Science ®Google Scholar
• Fulco M, Cen Y, Zhao P, et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell. 2008;14(5):661–673. doi:10.1016/j.devcel.2008.02.004.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Ye TJ, DeCaro E, et al. Intestinal SIRT1 Deficiency Protects Mice from Ethanol-Induced Liver Injury by Mitigating Ferroptosis. Am J Pathol. 2020;190(1):82–92. doi:10.1016/j.ajpath.2019.09.012.
   PubMed Web of Science ®Google Scholar
• Yan F, Zhang J, Zhang L, et al. Mulberry anthocyanin extract regulates glucose metabolism by promotion of glycogen synthesis and reduction of gluconeogenesis in human HepG2 cells. Food Funct. 2016;7:425–433. doi:10.1039/c5fo00841g.
   PubMed Web of Science ®Google Scholar
• Anyamaneeratch K, Rojvirat P, Sukjoi W, et al. Insights into transcriptional regulation of hepatic glucose production. Int Rev Cell and Mol Biol. 2015;318:203–253. doi:10.1016/bs.ircmb.2015.05.004.
   PubMedGoogle Scholar